New antibiotic eye drops aim to cure pink eye faster
NCT ID NCT06911424
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether fusidic acid 1% eye drops can cure bacterial conjunctivitis (pink eye) better than a placebo. About 400 adults and children with confirmed bacterial infection will receive either the antibiotic or placebo drops for a short time. The study measures how many people are cured and if the bacteria are cleared from the eye.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fusidic acid 1% eye drops
What this could lead to
If successful, this could provide a proven antibiotic eye drop option for treating bacterial conjunctivitis, potentially reducing symptoms faster than no treatment.
What could go wrong
This is a late-stage trial, but the effect must beat a placebo. Bacterial conjunctivitis often clears on its own, so the benefit may be modest. Side effects from eye drops are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baxis Site 01
RECRUITINGMiami, Florida, 33155, United States
Contact Email: •••••@•••••
-
Baxis Site 02
TERMINATEDHumble, Texas, 77338, United States
-
Baxis Site 03
TERMINATEDMiami, Florida, 33176, United States
-
Baxis Site 04
RECRUITINGLittle Rock, Arkansas, 72205, United States
Contact Email: •••••@•••••
-
Baxis Site 05
TERMINATEDMount Airy, North Carolina, 27030, United States
-
Baxis Site 06
RECRUITINGOrland Park, Illinois, 60462, United States
Contact Email: •••••@•••••
-
Baxis Site 08
RECRUITINGEdinburg, Texas, 78539, United States
Contact Email: •••••@•••••
-
Baxis Site 09
WITHDRAWNPittsburgh, Pennsylvania, 15227, United States
-
Baxis Site 10
RECRUITINGTampa, Florida, 33613, United States
Contact Email: •••••@•••••
-
Baxis Site 11
RECRUITINGLake Worth, Florida, 33460, United States
Contact Email: •••••@•••••
-
Baxis Site 12
RECRUITINGCharleston, South Carolina, 29414, United States
Contact Email: •••••@•••••
-
Baxis Site 13
TERMINATEDMiami Beach, Florida, 33140, United States
-
Baxis Site 14
TERMINATEDKingwood, Texas, 77345, United States
-
Baxis Site 15
TERMINATEDIdaho Falls, Idaho, 83404, United States
-
Baxis Site 16
WITHDRAWNWest Valley City, Utah, 84120, United States
-
Baxis Site 17
TERMINATEDLayton, Utah, 84041, United States
-
Baxis Site 18
TERMINATEDLayton, Utah, 84041, United States
-
Baxis Site 19
RECRUITINGLa Jolla, California, 92037, United States
Contact Email: •••••@•••••
-
Baxis Site 20
TERMINATEDSherman Oaks, California, 91423, United States
-
Baxis Site 21
TERMINATEDNorth Las Vegas, Nevada, 89030, United States
-
Baxis Site 22
TERMINATEDDoral, Florida, 33172, United States
-
Baxis Site 23
WITHDRAWNBabylon, New York, 11702, United States
-
Baxis Site 24
WITHDRAWNHuntington Beach, California, 92647, United States
-
Baxis Site 25
WITHDRAWNTulsa, Oklahoma, 74133, United States
-
Baxis Site 26
WITHDRAWNColumbia, Maryland, 21045, United States
-
Baxis Site 27
RECRUITINGLutz, Florida, 33549, United States
Contact Email: •••••@•••••
-
Baxis Site 28
RECRUITINGMiami Lakes, Florida, 33014, United States
Contact Email: •••••@•••••
-
Baxis Site 29
RECRUITINGPalm Springs, Florida, 33461, United States
Contact Email: •••••@•••••
-
Baxis Site 30
RECRUITINGGresham, Oregon, 97030, United States
Contact Email: •••••@•••••
-
Baxis Site 31
RECRUITINGLos Angeles, California, 90020, United States
Contact Email: •••••@•••••
-
Baxis Site 32
RECRUITINGCharlottesville, Virginia, 22902, United States
Contact Email: •••••@•••••
-
Baxis Site 33
RECRUITINGGreenville, South Carolina, 29607, United States
Contact Email: •••••@•••••
-
Baxis Site 34
RECRUITINGDelray Beach, Florida, 33484, United States
Contact Email: •••••@•••••
-
Baxis Site 35
RECRUITINGUnion City, Georgia, 30291, United States
Contact Email: •••••@•••••
-
Baxis Site 36
RECRUITINGMission, Texas, 78572, United States
Contact Email: •••••@•••••
-
Baxis Site 37
RECRUITINGLargo, Florida, 33773, United States
Contact Email: •••••@•••••
-
Baxis Site 38
RECRUITINGLos Angeles, California, 90048, United States
Contact Email: •••••@•••••
-
Baxis Site 39
RECRUITINGLong Beach, California, 90813, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.